title: Multicenter evaluation of the safety, tolerance, and efficacy of OptiMARK in magnetic resonance imaging of the brain and spine.
authors.affiliation: Department of Neuroradiology, University of Pennsylvania Medical Center, Philadelphia, USA.
authors.forename: R
authors.initials: R
authors.lastname: Grossman
authors.forename: M J
authors.initials: MJ
authors.lastname: Kuhn
authors.forename: K
authors.initials: K
authors.lastname: Maravilla
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Schild
authors.forename: R
authors.initials: R
authors.lastname: Ethier
authors.forename: M
authors.initials: M
authors.lastname: Reiser
authors.forename: W T
authors.initials: WT
authors.lastname: Yuh
authors.forename: A Y
authors.initials: AY
authors.lastname: Olukotun
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology*; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects; D013131:Spine / Q000473:pathology*
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; D005682:Gadolinium; C112666:gadoversetamide